Vivani Medical, Inc.
VANI
$1.34
$0.010.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.41M | 9.31M | 8.77M | 8.93M | 8.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.20M | 26.79M | 25.01M | 24.68M | 24.43M |
| Operating Income | -27.20M | -26.79M | -25.01M | -24.68M | -24.43M |
| Income Before Tax | -26.03M | -25.54M | -23.75M | -23.49M | -23.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.03 | -25.54 | -23.75 | -23.49 | -23.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.03M | -25.54M | -23.75M | -23.49M | -23.46M |
| EBIT | -27.20M | -26.79M | -25.01M | -24.68M | -24.43M |
| EBITDA | -26.81M | -26.38M | -24.60M | -24.28M | -24.03M |
| EPS Basic | -0.44 | -0.44 | -0.42 | -0.43 | -0.44 |
| Normalized Basic EPS | -0.28 | -0.28 | -0.26 | -0.27 | -0.28 |
| EPS Diluted | -0.44 | -0.44 | -0.42 | -0.43 | -0.44 |
| Normalized Diluted EPS | -0.28 | -0.28 | -0.26 | -0.27 | -0.28 |
| Average Basic Shares Outstanding | 235.61M | 231.15M | 226.93M | 219.89M | 213.50M |
| Average Diluted Shares Outstanding | 235.61M | 231.15M | 226.93M | 219.89M | 213.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |